Targeted drug delivery can be achieved by physical, biological, or molecular systems that result in high concentrations of the pharmacologically active agent at the pathophysiologically relevant site. If successful, the result of the targeting would be a significant reduction in drug toxicity, reduction of the drug dose, and increased treatment efficacy. Nanodevices represent a superior carrier platform for targeted drug delivery. Targeted delivery via selective cellular markers can potentially increase the efficacy and reduce the toxicity of therapeutic agents.
BME faculty members associated with research field:
Weiping Ren, MD, Ph.D. Associate Professor